I tried to purchase the related report 'Sprifermin Emerging Drug Insight and Market Forecast - 2032' but it seems to costs thousands!
I note two things already which give me hope.
I read in the link that their injection is intra-articular (into the joint), whereas ours is subcutaneous (under the skin) which I recall Mozz saying is the more comfortable option. (That's right, yes, Mozz?) I didn't see how many injections are required so that could be a deal breaker if results are similar.
Retreatment is required every 6-12 months, more frequently than ours, again in our favour.
I think there has been discussion about Sprifermin before on this platform. If anyone remembers where I can find it, I would appreciate your help.
General OA media and info, page-654
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.015(6.52%) |
Mkt cap ! $85.7M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.5¢ | 23.0¢ | $116.0K | 491.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 33682 | 3 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |